ARTICLE | Clinical News
EXC 001: Phase II data
August 9, 2010 7:00 AM UTC
In a double-blind, U.S. Phase II trial in an undisclosed number of patients undergoing elective abdominoplasty, intradermal injections of EXC 001 led to significant improvements in scarring in both ph...